Abuse and dependence potential of sphingosine-1-phosphate (S1P) receptor modulators used in the treatment of multiple sclerosis: a review of literature and public data

por Schoedel, Kerri A., Kolly, Carine, Gardin, Anne, Neelakantham, Srikanth, Shakeri-Nejad, Kasra
Publicado 2021

Impact of siponimod on vaccination response in a randomized, placebo-controlled study

por Ufer, Mike, Shakeri-Nejad, Kasra, Gardin, Anne, Su, Zhenzhong, Paule, Ines, Marbury, Thomas C., Legangneux, Eric
Publicado 2017

Effects of triclabendazole and its metabolite exposure on the heart‐rate–corrected QT intervals: A randomized, placebo‐ and positive‐controlled thorough QT study in healthy individ...

por Prince, William T., Venishetty, Vinay Kumar, Lecot, Jean, Shakeri‐Nejad, Kasra, Gray, Cathy, Taylor, Amanda, Iyer, Ganesh R., Zack, Julia
Publicado 2023

Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects

por Gardin, Anne, Ufer, Mike, Legangneux, Eric, Rossato, Gianluca, Jin, Yi, Su, Zhenzhong, Pal, Parasar, Li, Wenkui, Shakeri-Nejad, Kasra
Publicado 2018

Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence

por Hach, Thomas, Shakeri-Nejad, Kasra, Bigaud, Marc, Dahlke, Frank, de Micco, Massimiliano, Petricoul, Olivier, Graham, Gordon, Piani-Meier, Daniela, Turrini, Renato, Brinkmann, Volker, Nicoletti, Ferdinando
Publicado 2023